{"_links":{"self":[{"href":"/project/GID-HUB10002"}]},"_embedded":{"nice.indev:panel-list":{"_links":{"self":[{}]},"ETag":null}},"ETag":"01000000-0000-0001-0000-00000000037B","Summary":null,"Description":null,"ReferralDate":null,"SuspendDiscontinuedReason":null,"SuspendDiscontinuedUrl":null,"SuspendDiscontinuedUrlText":null,"LegacyModel":false,"ProductReference":null,"EvidenceAssessmentGroup":null,"Alert":null,"Content":"<p>This webpage covers all NICE&rsquo;s guidelines on cardiometabolic disease prevention and treatment The table presents the guidelines alphabetically within their topic area. Updates planned or in progress and areas we&rsquo;re&nbsp;<a href=\"https://www.nice.org.uk/hub/indevelopment/gid-hub10002/#methods\">actively monitoring</a>&nbsp;are listed for each guideline, and there are links to the individual update pages for more information.</p>\r\n<h2>Guidelines</h2>\r\n<h3>Cardiovascular disease</h3>\r\n<table border=\"1\" width=\"100%\">\r\n<thead>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><strong>Guideline</strong></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><strong>Updates planned and in progress</strong></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><strong>Key topic areas we&rsquo;re proposing to&nbsp;<a href=\"https://www.nice.org.uk/hub/indevelopment/gid-hub10002/#methods\">actively monitor</a></strong></p>\r\n</td>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng156\">Abdominal aortic aneurysm: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng185\">Acute coronary syndromes</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg187\">Acute heart failure: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng196\">Atrial fibrillation: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph15\">Cardiovascular disease: identifying and supporting people most at risk of dying early</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph25\">Cardiovascular disease prevention</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg181\">Cardiovascular disease: risk assessment and reduction, including lipid modification</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>Update in progress:</p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10368\">Escalation of therapy</a></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng106\">Chronic heart failure in adults: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>Update in progress:</p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10405\">Pharmacological treatment</a></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg71\">Familial hypercholesterolaemia: identification and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng208\">Heart valve disease presenting in adults: investigation and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng136\">Hypertension in adults: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg147\">Peripheral arterial disease: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg95\">Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg126\">Stable angina: management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng128\">Stroke and transient ischaemic attack in over 16s: diagnosis and initial management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg168\">Varicose veins: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng158\">Venous thromboembolic diseases: diagnosis, management and thrombophilia testing</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng89\">Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<h3>Diabetes</h3>\r\n<table border=\"1\" width=\"100%\">\r\n<thead>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><strong>Guideline</strong></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><strong>Updates planned and in progress</strong></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><strong>Key topic areas we&rsquo;re proposing to&nbsp;<a href=\"https://www.nice.org.uk/hub/indevelopment/gid-hub10002/#methods\">actively monitor</a></strong></p>\r\n</td>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng3\">Diabetes in pregnancy: management from preconception to the postnatal period</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#gestational-diabetes\">Diagnosis of gestational diabetes</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#preconception-planning-and-care\">Preconception planning and care: HbA1c targets</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#antenatal-care-for-women-with-diabetes\">Antenatal care for women with diabetes: blood glucose targets</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#preconception-planning-and-care\">Preconception planning and care: safety of diabetes medicines before, during and after pregnancy</a></p>\r\n<p>Blood glucose monitoring from preconception to postnatal period:</p>\r\n<ul>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#preconception-planning-and-care\">Preconception planning and care: monitoring blood glucose and ketones before pregnancy</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#antenatal-care-for-women-with-diabetes\">Antenatal care for women with diabetes: monitoring blood glucose, target levels, and continuous glucose monitoring</a></li>\r\n</ul>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng3/chapter/Recommendations#antenatal-care-for-women-with-diabetes\">Renal assessment during pregnancy</a></p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18\">Diabetes (type 1 and type 2) in children and young people: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#type-1-diabetes\">Education and information: type 1 diabetes</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#diabetic-ketoacidosis\">Ketone monitoring</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#type-1-diabetes\">Blood glucose monitoring frequency and techniques: type 1 diabetes</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#type-2-diabetes\">Metformin for type 2 diabetes</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#diabetic-ketoacidosis\">Fluid therapy for diabetic ketoacidosis</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#type-1-diabetes\">Diabetic retinopathy: type 1 diabetes</a>&nbsp;and&nbsp;<a href=\"https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#type-2-diabetes\">type 2 diabetes</a></p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng19\">Diabetic foot problems: prevention and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng19\">Diabetic foot problems: prevention and management</a></p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17\">Type 1 diabetes in adults: diagnosis and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#diagnosis-and-early-care-plan\">Diagnosis</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#education-and-information\">Education and information</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#ketone-monitoring-and-managing-diabetic-ketoacidosis\">Ketone monitoring</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#caring-for-adults-with-type-1-diabetes-in-hospital\">Care during other illness: blood glucose control in hospital</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#insulin-therapy\">Insulin therapy</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#managing-complications\">Managing complications: diabetic kidney disease, eye disease, gastroparesis, erectile dysfunction</a></p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28\">Type 2 diabetes in adults: management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>Update in progress:</p>\r\n<ul>\r\n<li><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10336\">Medicines (excluding insulin)</a></li>\r\n</ul>\r\n</td>\r\n<td width=\"40%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#dietary-advice-and-bariatric-surgery\">Dietary advice</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28/chapter/recommendations#drug-treatment\">Insulin-based therapy</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#drug-treatment\">Medicines other than insulin</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#diagnosing-and-managing-hypertension\">Diagnosing and managing hypertension</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#drug-treatment\">Assessment and treatment of cardiovascular risk factors</a></p>\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#managing-complications\">Managing complications: chronic kidney disease, eye disease, gastroparesis, erectile dysfunction</a></p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph38\">Type 2 diabetes: prevention in people at high risk</a></p>\r\n</td>\r\n<td width=\"24%\">-</td>\r\n<td width=\"40%\">\r\n<p>Risk assessment:</p>\r\n<ul>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#risk-assessment\">Risk assessment</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#encouraging-people-to-have-a-risk-assessment\">Encouraging risk assessment</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#risk-identification-stage-1\">Stage 1 risk identification</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#risk-identification-stage-2\">Stage 2 risk identification</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#matching-interventions-to-risk\">Matching interventions to risk</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#reassessing-risk\">Reassessing risk</a></li>\r\n</ul>\r\n<p>Intensive lifestyle-change programmes:</p>\r\n<ul>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#commissioning-risk-identification-and-intensive-lifestyle-change-programmes\">Commissioning</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#quality-assured-intensive-lifestyle-change-programmes-design-and-delivery\">Design and delivery</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#quality-assured-intensive-lifestyle-change-programmes-content\">Content</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#quality-assured-intensive-lifestyle-change-programmes-evaluation\">Evaluation</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#intensive-lifestyle-change-programmes-quality-assurance\">Quality assurance</a></li>\r\n</ul>\r\n<p>Medication:</p>\r\n<ul>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#metformin\">Metformin</a></li>\r\n<li><a href=\"https://www.nice.org.uk/guidance/ph38/chapter/Recommendations#orlistat\">Orlistat</a></li>\r\n</ul>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"34%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph35\">Type 2 diabetes prevention: population and community-level interventions</a></p>\r\n</td>\r\n<td width=\"24%\">-</td>\r\n<td width=\"40%\">&nbsp;</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<h3>Physical activity</h3>\r\n<table border=\"1\" width=\"100%\">\r\n<thead>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><strong>Guideline</strong></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><strong>Updates planned and in progress</strong></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><strong>Key topic areas we&rsquo;re proposing to&nbsp;<a href=\"https://www.nice.org.uk/hub/indevelopment/gid-hub10002/#methods\">actively monitor</a></strong></p>\r\n</td>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng90\">Physical activity and the environment</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph44\">Physical activity: brief advice for adults in primary care</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph54\">Physical activity: exercise referral schemes</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph17\">Physical activity for children and young people</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph13\">Physical activity in the workplace</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph41\">Physical activity: walking and cycling</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p>-</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<h3>Weight management</h3>\r\n<table border=\"1\" width=\"100%\">\r\n<thead>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><strong>Guideline</strong></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><strong>Updates planned and in progress</strong></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p><strong>Key topic areas we&rsquo;re proposing to&nbsp;<a href=\"https://www.nice.org.uk/hub/indevelopment/gid-hub10002/#methods\">actively monitor</a></strong></p>\r\n</td>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg189\">Obesity: identification, assessment and management</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/cg43\">Obesity prevention</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph42\">Obesity: working with local communities</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ng7\">Preventing excess weight gain</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p>Weight management before, during and after pregnancy</p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph47\">Weight management: lifestyle services for overweight or obese children and young people</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td width=\"33%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/ph53\">Weight management: lifestyle services for overweight or obese adults</a></p>\r\n</td>\r\n<td width=\"24%\">\r\n<p><a href=\"https://www.nice.org.uk/guidance/indevelopment/gid-ng10182\">Update in progress</a></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td width=\"40%\">\r\n<p>To be confirmed</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<section id=\"methods\">\r\n<h2>Methods</h2>\r\n<p>Areas for active monitoring are identified by our&nbsp;<a href=\"https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/maintaining-and-updating-our-guideline-portfolio\">maintaining and updating our guideline portfolio process</a>&nbsp;including validation with stakeholders.</p>\r\n<p>Active monitoring is ongoing surveillance in key topic areas. It involves one or more of:</p>\r\n<ul>\r\n<li>monitoring studies in progress by systematically searching for ongoing studies and assessing the results when published</li>\r\n<li>monitoring newly published studies by continuous searching of newly published evidence</li>\r\n<li>system monitoring by systematically collating intelligence from the health and care system and working with partners to identify areas of change.</li>\r\n</ul>\r\n<p>Guideline recommendations are developed using the methods and processes in&nbsp;<a href=\"https://www.nice.org.uk/process/pmg20/chapter/introduction\">developing NICE guidelines: the manual</a>&nbsp;and the&nbsp;<a href=\"https://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-appendices-a-to-n-2549710189/chapter/appendix-m-interim-principles-for-methods-and-processes-for-supporting-digital-living-guideline\">interim principles for methods and processes for supporting digital living guideline recommendations</a>.</p>\r\n<p>If you have new information, intelligence or evidence relevant to any of the key topic areas listed above, please contact&nbsp;<a href=\"mailto:prioritisation@nice.org.uk\">prioritisation@nice.org.uk</a>.</p>\r\n</section>","Reference":"GID-HUB10002","ProjectType":"HUB","TechnologyType":null,"ProductTypeName":"Hub","Process":"HUB","Title":"Cardiometabolic disease prevention and treatment guidelines","Status":"InProgress","ProjectGroup":"Other","PublishedDate":null,"LastModifiedDate":"2023-11-15T13:31:31.2652015","FirstGoLiveDate":"2023-08-23T05:30:34.2135242","CreatedDate":"2023-07-12T16:25:34.6044074","DevelopedAs":"CG","RelevantTo":null,"IdNumber":null,"AreasOfInterestList":[],"TopicSelectionDecision":"AwaitingDecision","TopicSelectionReason":null,"TopicSelectionDecisionDate":null,"TopicSelectionFurtherInfo":null,"IndicatorSubTypes":[]}